Abstract
The present pilot study was undertaken to investigate the impaired acquired color vision on Calabrian male sample showing this parameter as a biological marker in type 2 diabetes. All patients and controls underwent three pseudo-isochromatic clinical test batteries: Ishihara test, Farnsworth test, and City University test. The results show a specific loss of short-wavelength (blue sensitivity) and typical tritan responses in diabetic patients. Generally, in later stages of the disease, the red-green mechanisms are involved. By the impaired color vision study in diabetic patients, we can confirm the impaired retina-brain cortex pathway. We believe that the above not invasive test analysis can support the other instrumental and imaging analysis to study the impaired retina-brain cortex pathway. Moreover, we think that the present clinical method can be useful in terms of preventive medicine.
References
Zeki S (2003) A vision of the brain. Blackwell Scientific Publication, Oxford
Birch J (2001) Diagnosis of defective colour vision. Butterworth-Heinemann, Oxford
Piro A, Tagarelli A, Nicoletti G, Fletcher R, Quattrone A (2014) Color vision impairment in Parkinson’s disease. JPD 4:317–319
Lombrail P, Cathelineau G, Gervasis P, Thibult N (1984) Abnormal color vision and reliable self monitoring of blood glucose. Diabetes Care 7:318–321
Kurtenbach A, Wagner U, New A, Schiefer U, Ranke MB, Zenner E (1994) Brightness matching and colour discrimination in young diabetics without retinopathy. Vis Res 34:115–122
Gegenfurtner KR (2003) Cortical mechanismsm of colour vision. Nat Rev Neurosci 4:563–572
Solomon SG, Lennie P (2007) The machinery of colour vision. Nat Rev Neurosci 8:276–286
Martin PR (2004) Colour through the thalamus. Clin Exp Optom 87:249–257
Lee BB (2004) Paths to colour in the retina. Clin Exp Optom 87:239–248
Lee BB, Sun H, Zucchini W (2007) The temporal properties of the response of macaque ganglion cells and central mechanisms of flicker detection. J Vis 15:1–16
Hardy KJ, Lipton J, Scase MO, Foster DH, Scarpello JHB (1992) Detection of colour vision of abnormalities in uncomplicated type 1 diabetic patients with angiographically normal retinas. J Ophthalmol 76:461–464
Fletcher R, Voke J (1985) Defective color vision. Fundamental, diagnosis and management. Hilger, Bristol
Lakowski R, Aspinall PA, Kinnear PR (1972) Association between colour vision losses and diabetes mellitus. Ophthalmic Res 4:145–159
Lyon MF (1961) Gene action in the X-chromosome of the mouse (mus musculus L.). Nature 190:372–373
Tagarelli A, Piro A, Tagarelli G, Zinno F (2000) Color-blindness in Calabria (Southern Italy): a north-south decreasing trend. Am J Hum Biol 12:17–24
Ishihara S (1982) The series of plates designed as a test of colour-blindness, 38 plates edn. Kanehara S. Co. Ltd, Tokyo
Farnsworth D (1943) The Farnsworth-Munsell 100 hue and dichotomous test for color vision. J Opt Soc Am 33:568–578
Fletcher RJ (1975) The City University color vision test, 3rd edn. Keeler Instruments, London
Magarinos AM, McEwen BS (2000) Experimental diabetes in rats causes hippocampal dendritic and synaptic reorganization and increased glucocorticoid reactivity to stress. Proc Natl Acad Sci U S A 97:11056–11071
Reagan LP, Magarinos AM, McEwen BS (1999) Neurological changes induced by stress in streptozotocin diabetic rats. Acad N Y Acad Sci 893:126–137
Grillo CA, Piroli GG, Wood GE, Reznikov LR, McEwen BS, Reagan LP (2005) Immunocytochemical analysis of synaptic proteins provides new insights into diabetes-mediated plasticity in the rat hippocampus. Neuroscience 136:477–486
Nakagami HM, Yamamoto R, Yoshimura K, Taniyama SI, Aoki Y, Matsubara M et al (2001) Phosphorilation of p 38 mitogen-activted protein kinase downstream of bax-caspase 3 pathway leads to cell death induced by high alfa-glucose in humans endothelial cells. Diabetes 50:1472–1481
Grützner P, Schleicher S (1972) Acquired color vision defects in glaucoma patients. Mod Probl Ophthalmol 11:136–140
Marrè M (1973) The investigation of acquired colour vision deficiencies. In: Colour 73. Adam Hilger, London, pp 99–135
Dubois-Poulsen A (1952) Colour vision in brain lesions. In: Verriest G (ed) Colour vision deficiences VI. Junk, The Hague, pp 429–440
Acknowledgments
The authors thank Istituto Nazionale Riposo e Cura per Anziani (INRCA), Cosenza (Calabria, Southern Italy) to have checked into the hospital our patients. This study is part of the research project “Color vision in neurological, metabolic, and cardio-vascular diseases” from the National Researches Council approved by the Ethical Committee.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Piro, A., Tagarelli, A., Lagonia, P. et al. Color vision study to assess the impaired retina-brain cortex pathway in type 2 diabetes: a pilot study in Calabria (Southern Italy). Neurol Sci 40, 1939–1942 (2019). https://doi.org/10.1007/s10072-019-03894-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-019-03894-4